Aroop Mohanty | Microbiology | Best Researcher Award

Posted on by sciencefather

Dr. Aroop Mohanty | Microbiology | Best Researcher Award

Associate Professor at AIIMS Gorakhpur, India.

Dr. Aroop Mohanty is an accomplished professional with a robust background in microbiology and infectious diseases. Currently serving as an Assistant Professor at AIIMS Gorakhpur, he holds extensive experience in teaching, clinical practice, and research. Dr. Mohanty completed his M.D. in Microbiology from SMIMS, Sikkim, and a Postgraduate Diploma in Infectious Diseases from the University of New South Wales. His research interests encompass innovative diagnostic methods, antimicrobial resistance, hospital-acquired infections, and microbiome studies. Dr. Mohanty has received recognition for his contributions, including awards for teaching excellence, research innovation, and leadership in antimicrobial stewardship. His commitment to advancing healthcare through rigorous research and education underscores his role as a leading figure in the field of microbiology.

Professional Profiles:

Education

Dr. Aroop Mohanty has pursued a rigorous academic journey, beginning with his schooling at K.V No: 1 in Ferozepur Cantt, Punjab, where he achieved an impressive 86.6% in his 10th grade examinations under the CBSE board in 2000. Continuing his academic excellence, he completed his 12th grade at K.V No: 2 in Bhubaneswar, Odisha, securing 77.2% in 2002. Dr. Mohanty then pursued his passion for medicine by obtaining his M.B.B.S degree with an internship from MCOMS, Pokhara, Nepal, affiliated with Kathmandu University, in 2010, with a notable first attempt success and a focus on comprehensive medical training. He further specialized in Microbiology, earning his M.D. from SMIMS, Gangtok, Sikkim, through Sikkim Manipal University in 2015, demonstrating his commitment to advanced medical knowledge. Driven by a quest for expertise in infectious diseases, he pursued and completed a Postgraduate Diploma in Infectious Diseases from the School of Public Health and Community Medicine at the University of New South Wales in 2018, further enriching his medical qualifications and global perspectives.

Professional Experience

Dr. Aroop Mohanty brings a wealth of experience in academic and clinical settings, currently serving as an Assistant Professor in the Department of Microbiology at AIIMS Gorakhpur since May 2020. Prior to this, he held the position of Assistant Professor at AIIMS Rishikesh from September 2019 to May 2020, where he contributed significantly to medical education and research. His earlier roles include Senior Resident at AIIMS Rishikesh from July 2016 to September 2019, where he gained extensive clinical experience and expertise in microbiology. Before joining AIIMS Rishikesh, Dr. Mohanty served as a Registrar at Kasturba Medical College Hospital in Mangalore from November 2015 to July 2016, where he further honed his skills in medical practice and patient care. Throughout his career, he has been actively involved in teaching undergraduate and paramedical students, conducting research, and contributing to hospital infection control measures and academic development.

Research Interest

Dr. Aroop Mohanty’s research interests encompass several key areas within microbiology and infectious diseases. He is particularly interested in investigating novel diagnostic methods for infectious pathogens, focusing on the development and evaluation of molecular and serological assays. His expertise extends to studying antimicrobial resistance patterns and mechanisms, aiming to contribute insights into combating emerging resistance trends through antimicrobial stewardship and innovative treatment strategies. Additionally, Dr. Mohanty is keen on exploring hospital-acquired infections and infection control measures, with a focus on improving surveillance techniques and implementing effective interventions to enhance patient safety. He is also interested in epidemiological studies of infectious diseases, including outbreak investigations and disease transmission dynamics, leveraging his clinical and academic background to inform public health strategies. Furthermore, Dr. Mohanty is passionate about the role of microbiota in health and disease, exploring the interactions between host microbiomes and infectious agents to advance understanding and therapeutic approaches in microbial ecology. His research aims to bridge the gap between basic science discoveries and clinical applications, ultimately contributing to advancements in infectious disease management and public health.

Award and Honors

Dr. Aroop Mohanty has garnered several prestigious awards and honors throughout his career, reflecting his outstanding contributions in the field of microbiology and infectious diseases. In 2023, he was awarded the “Outstanding Contribution in Microbiology Education” for his dedicated mentorship and exceptional teaching of medical students at AIIMS Gorakhpur, setting a benchmark in microbiology education. His research prowess earned him the “Research Excellence Award in Infectious Diseases” in 2022, recognizing his pioneering work in developing novel diagnostic methods and investigating antimicrobial resistance patterns. Dr. Mohanty was also honored with the “Best Poster Presentation at International Conference on Microbiology” in 2021 for his impactful research on hospital-acquired infections and infection control measures. His leadership in antimicrobial stewardship was acknowledged with the “Leadership in Antimicrobial Stewardship” award in 2018, highlighting his advocacy for responsible antimicrobial use and patient safety initiatives. Additionally, he received the “Gold Medal for Academic Excellence in MD Microbiology” in 2015 for achieving top academic performance during his MD studies at SMIMS, Sikkim Manipal University. Dr. Mohanty’s commitment to excellence in hospital infection control was recognized with the “Best Resident Award in Hospital Infection Control” in 2014, underscoring his dedication to ensuring high standards of patient care and safety.

Research Skills

Dr. Aroop Mohanty possesses comprehensive research skills honed through his extensive experience in microbiology and infectious diseases. He excels in identifying research questions and formulating hypotheses, drawing from his in-depth knowledge of pathogen biology and disease mechanisms. Dr. Mohanty is adept at conducting systematic literature reviews to explore existing research and identify gaps in knowledge, paving the way for innovative research directions. His expertise extends to designing and executing rigorous research methodologies, including both qualitative and quantitative approaches, such as molecular biology techniques, epidemiological studies, and clinical trials. He demonstrates proficiency in data collection and analysis, utilizing advanced statistical methods to interpret findings and draw meaningful conclusions. Dr. Mohanty is committed to ethical research practices, ensuring compliance with regulatory standards and contributing to the advancement of evidence-based practices in infectious disease management. His ability to effectively communicate research findings through publications and presentations underscores his role as a thought leader in microbiology research.

Publications

  1. Health problems in healthcare workers: A review
    • Authors: A Mohanty, A Kabi, AP Mohanty
    • Year: 2019
    • Citations: 166
    • Journal: Journal of family medicine and primary care 8 (8), 2568-2572
  2. Corona health‑care warriors in India: knowledge, attitude, and practices during COVID‑19 outbreak
    • Authors: YB Aroop Mohanty, Vanya Singh, Rajesh Kumar, Puneet Kumar Gupta
    • Year: 2021
    • Citations: 48
    • Journal: Journal of Education and Health Promotion 10, 1-9
  3. First Monkeypox deaths outside Africa: no room for complacency
    • Authors: R Sah, A Mohanty, A Abdelaal, A Reda, AJ Rodriguez-Morales
    • Year: 2022
    • Citations: 41
    • Journal: Therapeutic Advances in Infectious Disease 9, 20499361221124027
  4. Monkeypox viral detection in semen specimens of confirmed cases: a systematic review and meta‐analysis
    • Authors: A Reda, A Abdelaal, AM Brakat, BI Lashin, M Abouelkheir, B Abdelazeem
    • Year: 2023
    • Citations: 39
    • Journal: Journal of Medical Virology 95 (1), e28250
  5. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review
    • Authors: MA Shamim, BK Padhi, P Satapathy, SD Veeramachaneni, C Chatterjee
    • Year: 2023
    • Citations: 37
    • Journal: International Journal of Infectious Diseases 127, 150-161
  6. Effectiveness of Video-Based Online Training for Health Care Workers to Prevent COVID-19 Infection: An Experience at a Tertiary Care Level Institute, Uttarakhand, India
    • Authors: SR Rakesh sharma, Aroop Mohanty, Vanya Sharma, Puneet Kumar Gupta, Pratima Gupta
    • Year: 2021
    • Citations: 31
    • Journal: Cureus 13 (05), 01-11
  7. Monkeypox reported in India – South East Asia Region: Health and economic challenges
    • Authors: DK Sah R, Mohanty A, Siddiq A, Singh P, Abdelaal A, Alshahrani A
    • Year: 2022
    • Citations: 30
    • Journal: The Lancet Regional Health – Southeast Asia 4
  8. Public health emergency of international concern declared by the World Health Organization for monkeypox
    • Authors: R Sah, BK Padhi, A Siddiq, A Abdelaal, A Reda, B Ismail Lashin
    • Year: 2022
    • Citations: 27
    • Journal: Global Security: Health, Science and Policy 7 (1), 51-56
  9. Epidemiologic situation of HIV and Monkeypox Coinfection: A systematic review
    • Authors: B Ortiz-Saavedra, ES Montes-Madariaga, C Cabanillas-Ramirez, N Alva
    • Year: 2023
    • Citations: 25
    • Journal: Vaccines 11 (2), 246
  10. Potentially asymptomatic infection of monkeypox virus: a systematic review and meta-analysis
    • Authors: P Satapathy, P Mohanty, S Manna, MA Shamim, PP Rao, AK Aggarwal
    • Year: 2022
    • Citations: 24
    • Journal: Vaccines 10 (12), 2083

 

 

DEROSA LISA | Immunology and Microbiology | Best Researcher Award

Posted on by sciencefather

Assist Prof Dr. DEROSA LISA | Immunology and Microbiology | Best Researcher Award

MD, PhD at Gustave Roussy, France.

Associate Professor Dr. Lisa Derosa is a leading medical oncologist and researcher at Gustave Roussy Cancer Center (GRCC) in France, specializing in tumor immunology and cancer immunotherapy. With an MD from Pisa University and a PhD in Immunology from Paris-Sud University, she has significantly contributed to understanding the immunosuppressive role of antibiotics and the impact of gut microbiota on antitumor immunity. Since 2016, Dr. Derosa has pioneered research in these areas, earning numerous prestigious awards including the Conquer Cancer Foundation ASCO Merit Award and recognitions from ESMO and European Urology. She directs the ClinicoBiome Program at GRCC and co-directs the RHU Clinical Program Grant “Immunolife” and the EU Program Grant “Oncobiome.” Her research skills include clinical trial design, metagenomic analysis, immunological assays, and pharmacodynamic studies, making her a leader in microbiota-centered cancer therapies. Dr. Derosa’s collaborative approach and interdisciplinary projects have resulted in over 100 publications and significant advancements in cancer immunotherapy.

Professional Profiles:

Education

Associate Professor Dr. Lisa Derosa’s educational journey is marked by a series of prestigious degrees and certifications. In 2023, she became an Associate Professor of Immunology at Paris-Saclay University in France. Prior to that, in 2019, she earned her PhD in Immunology from Paris-Sud University and registered as a physician in France the same year. She also obtained a University Diploma in Animal Experimentation Level 1 from Sorbonne University, Paris, in 2018. Her earlier academic achievements include a Diplôme Universitaire Européen de Recherche Translationnelle Et Clinique en Cancérologie (DUERTECC) from Paris-Sud University and a Diplôme d’Université Carcinologie Clíniques (DUC) from Université Paris XI, both in 2016. Dr. Derosa completed her M2 in Pharmacology, Clinical Trial in Oncology at Pisa University in Italy in 2015 and became Board Certified in Medical Oncology from the same university in 2014. She first qualified as a physician in Italy in 2009, following her MD from the School of Medicine at Pisa University in 2008.

Professional Experience

Associate Professor Dr. Lisa Derosa has a distinguished career in medical oncology and cancer immunology. Since 2022, she has been serving as the Co-Coordinator of the RHU IMMUNOLIFE (PIA2) multi-team program project in France and as a member of the Scientific Advisory Board for everImmune. In the same year, she was appointed as an Associate Professor of Immunology at Paris-Saclay University and a Senior Research Associate in the Cancer Immunology Department at Gustave Roussy Cancer Center (GRCC). Dr. Derosa has also been the Clinical Director of the ClinicoBiome Program at GRCC since 2020 and has held the position of Medical Oncology Specialist at GRCC since 2020. From 2017 to 2021, she co-coordinated the PIA2 RHU TORINO LUMIERE project. She has also been a Co-Coordinator of the H2020 ONCOBIOME project since 2019. Prior to these roles, Dr. Derosa served as a clinical attending in the Genitourinary and Lung Department at GRCC from 2019 to 2020 and completed a clinical fellowship in the Genitourinary Medical Oncology Department at GRCC from 2016 to 2019. Before joining GRCC, she was a clinical attending in the Oncology Department at Hospital S. Chiara-Pisa from 2014 to 2016. Additionally, she gained valuable experience as a visiting student at GRCC in 2013 and at the Oncology Department at Ospedali Riuniti di Livorno from 2006 to 2008.

Award and Honors

Associate Professor Dr. Lisa Derosa has received numerous prestigious awards and honors throughout her career, reflecting her significant contributions to oncology and immunology. In 2023, she was honored with the Conquer Cancer Foundation ASCO Merit Award. The previous year, she received an accolade from the European Society for Medical Oncology (ESMO) at their Asia Annual Meeting. In 2021, she was awarded the Best Scientific Paper published on Fundamental Research by European Urology and also received the ASCO Merit Award in Lung Cancer, supported by Frances A. Shepherd. Her exceptional work earned her the EATI Award in 2020. The year 2018 was particularly notable, as she received the Best Paper Award from ESMO YOC, the ESMO Annual Meeting Award, the Early Detection of Cancer Conference Award from ARC, and the Conquer Cancer Foundation ASCO Merit Award. In 2017, she was recognized with multiple Conquer Cancer Foundation ASCO Merit Awards, including the Genitourinary Cancer Merit Award. In 2016, she was the recipient of the 5th Pieter de Mulder Memorial Prize and the ESMO Translational Research Fellowship Award. Her early career was distinguished by the AIOM Award for young researchers in Oncology in 2015, the ESMO Annual Meeting Award in 2014, and the ITT Stage in Oncology Award from the Istituto Toscano Tumori in 2013.

Research Interest

Associate Professor Dr. Lisa Derosa’s research interests lie at the intersection of tumor immunology and cancer immunotherapy, with a particular focus on the immunosuppressive role of antibiotics in cancer treatment and the impact of gut microbiota on antitumor immunity. Since 2016, she has been pioneering research in these areas, exploring how the composition of gut microbiota can regulate the effectiveness of immune checkpoint inhibitors. Her innovative work has led to significant insights into the microbiota’s role in cancer treatment, making her a leading figure in the development of microbiota-centered interventions. Dr. Derosa currently directs the Microbiota-Centered Intervention Program (ClinicoBiome) at Gustave Roussy Cancer Center and co-directs the RHU Clinical Program Grant “Immunolife” as well as the EU Program Grant “Oncobiome.” Her research continues to bridge clinical oncology with translational research, aiming to improve patient outcomes through a deeper understanding of the immune system’s interactions with cancer therapies.

Research Skills

Associate Professor Dr. Lisa Derosa possesses a comprehensive skill set in the field of cancer immunology and immunotherapy, characterized by her expertise in clinical and translational research. She has extensive experience in designing and conducting clinical trials, particularly those investigating the interactions between gut microbiota and immune checkpoint inhibitors. Dr. Derosa is skilled in metagenomic analysis, allowing her to identify microbiome-based biomarkers that predict patient response to immunotherapy. Her proficiency in immunological assays and molecular biology techniques has been instrumental in her research on the immunosuppressive effects of antibiotics and the regulatory role of gut microbiota in antitumor immunity. Additionally, she has a strong background in pharmacodynamic and pharmacokinetic studies, which she has applied in various phase II clinical trials. Dr. Derosa’s ability to integrate clinical data with cutting-edge laboratory research has made her a leader in the development of microbiota-centered cancer therapies. Her collaborative projects often involve multidisciplinary teams, highlighting her skills in project management and scientific communication.